X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with Fulford India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD vs FULFORD INDIA - Comparison Results

BIOCON LTD    Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON LTD FULFORD INDIA BIOCON LTD/
FULFORD INDIA
 
P/E (TTM) x 84.1 398.8 21.1% View Chart
P/BV x 7.9 6.2 127.4% View Chart
Dividend Yield % 0.2 0.1 185.0%  

Financials

 BIOCON LTD   FULFORD INDIA
EQUITY SHARE DATA
    BIOCON LTD
Mar-17
FULFORD INDIA
Mar-14
BIOCON LTD/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs1,162942 123.3%   
Low Rs483450 107.2%   
Sales per share (Unadj.) Rs194.6691.4 28.1%  
Earnings per share (Unadj.) Rs34.411.5 300.2%  
Cash flow per share (Unadj.) Rs48.315.4 314.2%  
Dividends per share (Unadj.) Rs1.002.00 50.0%  
Dividend yield (eoy) %0.10.3 42.3%  
Book value per share (Unadj.) Rs241.9380.0 63.7%  
Shares outstanding (eoy) m200.003.90 5,128.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.21.0 419.8%   
Avg P/E ratio x23.960.7 39.4%  
P/CF ratio (eoy) x17.045.3 37.6%  
Price / Book Value ratio x3.41.8 185.6%  
Dividend payout %2.917.4 16.7%   
Avg Mkt Cap Rs m164,4402,714 6,058.1%   
No. of employees `0009.20.4 2,079.7%   
Total wages/salary Rs m7,470505 1,479.2%   
Avg. sales/employee Rs Th4,213.96,073.0 69.4%   
Avg. wages/employee Rs Th809.01,137.4 71.1%   
Avg. net profit/employee Rs Th745.2100.7 740.2%   
INCOME DATA
Net Sales Rs m38,9112,696 1,443.1%  
Other income Rs m1,571125 1,252.8%   
Total revenues Rs m40,4822,822 1,434.6%   
Gross profit Rs m9,795-46 -21,109.9%  
Depreciation Rs m2,77215 18,236.8%   
Interest Rs m26010 2,736.8%   
Profit before tax Rs m8,33454 15,348.1%   
Minority Interest Rs m1630-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,61610 16,833.3%   
Profit after tax Rs m6,88145 15,393.7%  
Gross profit margin %25.2-1.7 -1,462.8%  
Effective tax rate %19.417.7 109.7%   
Net profit margin %17.71.7 1,066.7%  
BALANCE SHEET DATA
Current assets Rs m40,4771,738 2,328.5%   
Current liabilities Rs m16,783545 3,081.1%   
Net working cap to sales %60.944.3 137.6%  
Current ratio x2.43.2 75.6%  
Inventory Days Days6048 123.0%  
Debtors Days Days834 1,924.6%  
Net fixed assets Rs m45,07312 378,764.7%   
Share capital Rs m1,00039 2,564.1%   
"Free" reserves Rs m47,3771,443 3,283.2%   
Net worth Rs m48,3771,482 3,264.3%   
Long term debt Rs m21,0820-   
Total assets Rs m93,9422,077 4,523.6%  
Interest coverage x33.16.7 492.2%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.41.3 31.9%   
Return on assets %7.62.6 291.3%  
Return on equity %14.23.0 471.6%  
Return on capital %12.64.3 292.9%  
Exports to sales %00-   
Imports to sales %024.5 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA659 0.0%   
Fx inflow Rs m12,98817 75,511.6%   
Fx outflow Rs m7,899673 1,173.4%   
Net fx Rs m5,089-656 -775.8%   
CASH FLOW
From Operations Rs m6,40090 7,111.1%  
From Investments Rs m-4,985105 -4,765.8%  
From Financial Activity Rs m-1,775-14 12,588.7%  
Net Cashflow Rs m-473181 -262.0%  

Share Holding

Indian Promoters % 40.4 0.0 -  
Foreign collaborators % 20.6 75.0 27.5%  
Indian inst/Mut Fund % 8.4 3.8 221.1%  
FIIs % 10.7 0.1 10,700.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 21.2 93.9%  
Shareholders   109,995 4,783 2,299.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON LTD With:   FDC LTD.  UNICHEM LAB  WYETH LTD  AJANTA PHARMA  ALEMBIC LTD  

Compare BIOCON LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Volatile Note; Airtel, Idea Down by 5%(01:30 pm)

After opening the day in green share markets in India witnessed choppy trading activity and are presently trading above the dotted line.

Related Views on News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

'Smart Money' Enters Bitcoin. Will You?(Smart Contrarian)

Jan 17, 2018

As institutional money enters bitcoin, the gains over the last year could just be the tip of the iceberg.

Increasing Divergence Between Bond Yields and Earnings Yield(Chart Of The Day)

Jan 11, 2018

Over the past couple of months, bond yields have risen, but earning yields have fallen, increasing divergence.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON LTD SHARE PRICE


Jan 24, 2018 03:11 PM

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE BIOCON LTD WITH

MARKET STATS